Clinical trial
A Phase I-II Study of the Combination of Bendamustine and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
NCT01754402 is registered in ClinicalTrials.gov with Cristina Gasparetto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I-II Study of the Combination of Bendamustine and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
- Lead sponsor
- Cristina Gasparetto
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- January 7, 2013
- Completion date
- January 1, 2025
- Enrollment
- 56 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.